International Melanoma Algorithm Training Study - IMATS

SciBase AB1,800 enrolled

Overview

This is an international, multicenter, prospective, non controlled, non randomized, clinical study to collect electrical impedance data of potentially malignant pigmented nevi and histological diagnoses (International Melanoma Algorithm Training Study \[IMATS\]). The study objective is to collect data for training and optimization of an algorithm that can classify skin lesions using electrical impedance, i.e., to identify malignant melanomas.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

1,800

Conditions

Malignant Melanoma

Interventions

SciBase III Electrical Impedance SpectrometerDEVICE

Following enrollment, patients will undergo measurements with SciBase III Electrical Impedance Spectrometer. Electrical impedance of the skin will be measured with a microinvasive spiked probe.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women of any ethnic group * Lesion located on normal healthy skin * Maximum number of eight lesions per patient * etc. Exclusion Criteria: * Lesion under finger and toe nails * Lesion located on eczema, psoriasis areas or similar * Lesion located on scars * etc.

Locations (1)

Sahlgrenska University Hospital, Dpt. of Dermatology

Gothenburg, Sweden

Outcomes

Primary Outcomes

Outcome measure not applicable. This is an algorithm training study.

Time frame: Q1 2010

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.